The Director of the St Francis Medical Group, David Cooper, told 6PR Mornings that West Australian doctors are still being bogged down by red tape when trying to prescribe medicinal cannabis to their patients.
Earlier this month the Therapeutic Goods Administration (TGA) handed down its final decision in favour of down-scheduling low dose cannabidiol (CBD) preparations from Schedule 4 to Schedule 3, which means the drug will soon be available for purchase from Australian pharmacies over the counter.
Under the ruling, individuals will be able to purchase a maximum of 150 mg per day—which is a significant increase on the previously proposed limit of 60mg—while the implementation date has been brought forward to February 2021.
– Read the entire article at Benzinga.
Bud Digest[otw_is sidebar=otw-sidebar-8]